Trademark: 90813452
Word
ADROIQ
Status
Pending
Status Code
616
Status Date
Wednesday, February 14, 2024
Serial Number
90813452
Mark Type
4000
Filing Date
Tuesday, July 6, 2021
Published for Opposition
Tuesday, May 3, 2022

Trademark Owner History
EXTROVIS AG - Owner At Publication

Classifications
5 Anti-epileptic pharmaceutical preparations; Intravenous fluids used for rehydration, nutrition and the delivery of pharmaceutical preparations; Pharmaceutical preparations acting on the central nervous system; Pharmaceutical preparations and substances for the treatment of psychiatric diseases and disorders; Pharmaceutical preparations and substances for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; Pharmaceutical preparations for treating chemical imbalances; Pharmaceutical preparations for use in chemotherapy; Pharmaceutical preparations for the treatment of kidney diseases

Trademark Events
Feb 14, 2024
Notice Of Revival - E-Mailed
Feb 14, 2024
Petition To Revive-Granted
Feb 14, 2024
Teas Petition To Revive Received
Jan 29, 2024
Abandonment Notice E-Mailed - No Use Statement Filed
Jan 29, 2024
Abandonment - No Use Statement Filed
Jun 28, 2023
Notice Of Approval Of Extension Request E-Mailed
Jun 26, 2023
Sou Extension 2 Granted
Jun 26, 2023
Sou Extension 2 Filed
Jun 26, 2023
Sou Teas Extension Received
Dec 28, 2022
Notice Of Approval Of Extension Request E-Mailed
Dec 26, 2022
Sou Extension 1 Granted
Dec 26, 2022
Sou Extension 1 Filed
Dec 26, 2022
Sou Teas Extension Received
Jun 28, 2022
Noa E-Mailed - Sou Required From Applicant
May 3, 2022
Official Gazette Publication Confirmation E-Mailed
May 3, 2022
Published For Opposition
Apr 13, 2022
Notification Of Notice Of Publication E-Mailed
Mar 28, 2022
Approved For Pub - Principal Register
Mar 28, 2022
Examiner's Amendment Entered
Mar 28, 2022
Notification Of Examiners Amendment E-Mailed
Mar 28, 2022
Examiners Amendment E-Mailed
Mar 28, 2022
Examiners Amendment -Written
Mar 24, 2022
Assigned To Examiner
Sep 15, 2021
New Application Office Supplied Data Entered
Jul 10, 2021
Teas Change Of Correspondence Received
Jul 10, 2021
Teas Change Of Domestic Representatives Address
Jul 10, 2021
Attorney/Dom.Rep.Revoked And/Or Appointed
Jul 10, 2021
Teas Revoke/App/Change Addr Of Atty/Dom Rep Received
Jul 9, 2021
New Application Entered

Trademark Alertz updated from USPTO on 2030-01-24